MED-X has filed a notice of an exempt offering of securities to raise $3,450,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, MED-X is raising $3,450,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Matthew Mills played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About MED-X
Med-X, Inc. innovates, researches, and develops a variety of all-natural and alternative solutions to everyday problems. Currently, Med-X products provide effective nontoxic and 100% all-natural pest management products to cannabis cultivators. These same products are currently used widely in the pest control and hospitality arenas nationally. Through The Marijuana Times magazine, the media division of Med-X, we aim to educate and provide engaging articles and facts about the cannabis community. Our mission is to advance the medical and recreational cannabis industry by educating the community and developing products that are safe, effective, and affordable. With an all-star management team and experienced doctors at the helm, Med-X is blazing the trail of the green scene with products aimed at helping people to live better lives. Med-X, Inc. is already working on various stages of automation that will change the cannabis market forever.
To learn more about MED-X, visit http://medx-rx.com/
Contact:
Matthew Mills, Chief Executive Officer
818-349-2870
https://www.linkedin.com/in/matthew-dole-5b512540/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.